OXYTROL FOR WOMEN OTC
Generic Name and Formulations:
Oxybutynin 3.9mg/day; transdermal patch.
Merck Consumer Care, Inc.
Indications for OXYTROL FOR WOMEN:
Overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
≥18yrs: Apply to clean, dry and smooth area on the abdomen, hips, or buttocks. Use 1 patch for 4 days in a row. Remove patch after 4 days and apply new one. Rotate application sites. Dispose properly with sticky sides together.
<18yrs: not recommended.
Male patients. Pain or burning when urinating. Blood in urine. Unexplained lower back or side pain. Cloudy or foul-smelling urine. Stress incontinence. Urinary or gastric retention. Glaucoma.
Consider other causes of frequent urination (eg, UTI, diabetes, early pregnancy). Unexplained weight loss. Hepatic or renal impairment. Reevaluate if condition worsens or no improvement after 2 weeks. Nursing mothers.
Additive effects with alcohol, other anticholinergic drugs. Caution with antibiotics (eg, erythromycin, clarithromycin) or antifungals (eg, ketoconazole, itraconazole).
Local reactions (eg, itching, rash, redness), sleepiness, dizziness, blurry vision.
Endocrinology Advisor Articles
- Triple-Goal Achievement Reduces Risk for Complications in Type 2 Diabetes
- Inverse Association Between Serum 25(OH)D Levels and Risk for Diabetes
- ADA Issues White Paper Addressing Escalating Cost of Insulin
- Neprilysin Inhibition May Reduce Renal Function Deterioration in Comorbid T2D and Chronic Heart Failure
- Serum Chemerin May Predict Risk for Spontaneous Abortion in Women With PCOS
- Diabetes Treatments
- Incretins, Thiazolidinediones Associated With Better Glycemic Control in T2D
- No Link Between HbA1c Levels and Wound Healing in Patients With Diabetic Foot Ulcers
- Risk for Fetal Loss Early in Pregnancy Not Greater With Noninsulin vs Insulin Therapy
- Use of In-Hospital Continuous Subcutaneous Insulin Infusion: A Consensus Statement
- Effects of Gender on Clinical Outcomes in Empagliflozin-Treated Type 2 Diabetes
- Effect of Acetyl-L-Carnitine on Blood Pressure in Type 2 Diabetes
- PAH Risk, Mortality Increased by Disturbances in Male Sex Hormones
- Perioperative Cardiovascular Events More Common in Diabetes
- Individuals With Type 1 Diabetes See Improvement With Continuous Glucose Monitoring